Cargando…
Identification of Novel Diagnostic Markers for Malignant Pleural Mesothelioma Using a Reverse Translational Approach Based on a Rare Synchronous Tumor
Although the routine use of immunohistochemistry has improved the accuracy of histopathologic diagnosis in clinical practice, new methods for discovering novel diagnostic markers are still needed. We sought new diagnostic markers for malignant pleural mesothelioma (MPM) using a reverse translational...
Autores principales: | Naka, Tomoaki, Hatanaka, Yutaka, Tabata, Yukiko, Takasawa, Akira, Akiyama, Hideo, Hida, Yasuhiro, Okada, Hiromi, Hatanaka, Kanako C., Mitsuhashi, Tomoko, Kushitani, Kei, Amatya, Vishwa Jeet, Takeshima, Yukio, Inai, Kouki, Kaga, Kichizo, Matsuno, Yoshihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871196/ https://www.ncbi.nlm.nih.gov/pubmed/35204409 http://dx.doi.org/10.3390/diagnostics12020316 |
Ejemplares similares
-
Comparative genetic analysis of a rare synchronous collision tumor composed of malignant pleural mesothelioma and primary pulmonary adenocarcinoma
por: Naka, Tomoaki, et al.
Publicado: (2016) -
Utility of Survivin, BAP1, and Ki-67 immunohistochemistry in distinguishing epithelioid mesothelioma from reactive mesothelial hyperplasia
por: Kushitani, Kei, et al.
Publicado: (2018) -
Downregulation of FTL decreases proliferation of malignant mesothelioma cells by inducing G(1) cell cycle arrest
por: Kambara, Takahiro, et al.
Publicado: (2022) -
miR-182 and miR-183 Promote Cell Proliferation and Invasion by Targeting FOXO1 in Mesothelioma
por: Suzuki, Rui, et al.
Publicado: (2018) -
CD9 expression as a favorable prognostic marker for patients with malignant mesothelioma
por: AMATYA, VISHWA JEET, et al.
Publicado: (2012)